{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:25:17Z","timestamp":1791595517463,"version":"4.3.4"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/coc.0b013e318201a406","type":"journal-article","created":{"date-parts":[[2011,2,4]],"date-time":"2011-02-04T01:31:29Z","timestamp":1296783089000},"page":"504-509","source":"Crossref","is-referenced-by-count":65,"title":["Prostate Cancer, Androgen Deprivation Therapy, Obesity, the Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease"],"prefix":"10.1097","volume":"35","author":[{"given":"Andrew","family":"Collier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"McGlynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Hollins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-18-20210128","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jnci\/85.12.979","article-title":"Noncancer deaths in white adult cancer patients.","volume":"85","author":"Brown","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R3-18-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clon.2008.11.013","article-title":"Metabolic syndrome and prostate cancer: a review.","volume":"21","author":"Nobes","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R4-18-20210128","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndromea new worldwide definition.","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"R7-18-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-5347(05)64820-3","article-title":"Studies on prostatic cancer: I. the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.","volume":"168","author":"Huggins","year":"2002","journal-title":"J Urol"},{"key":"R9-18-20210128","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMe0901737","article-title":"Androgen deprivation in prostate cancerstep by step.","volume":"360","author":"Albertsen","year":"2009","journal-title":"N Engl J Med"},{"key":"R10-18-20210128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pros.2990040605","article-title":"New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens.","volume":"4","author":"Labrie","year":"1983","journal-title":"Prostate"},{"key":"R11-18-20210128","first-page":"1420","article-title":"A controlled trial of leuprolide with and without flumatide in prostatic carcinoma. N Eng J Med. 1989;321:419-424 .","volume":"321","author":"Crawford","year":"1989","journal-title":"Erratum"},{"key":"R12-18-20210128","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0360-3016(01)01579-6","article-title":"Phase 111 radiation therapy group (RTOG) trial 86-10 of androgen deprivation therapy adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.","volume":"50","author":"Pilepich","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-18-20210128","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1200\/jco.2007.25.18_suppl.5014","article-title":"EORTC Radiation Oncology and Genito-Urinary Tract Cancer Groups. Concomitant and adjuvant androgen deprivation (ADT) with external beam irradiation (RT) for locally advanced prostate cancer: 6 months versus 3 years AADTResults of the randomised EORTC phase III trial 22961.","volume":"25","author":"Bolla","year":"2007","journal-title":"J Clin Oncol"},{"key":"R14-18-20210128","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.22628","article-title":"Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.","volume":"109","author":"DAmico","year":"2007","journal-title":"Cancer"},{"key":"R15-18-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0936-6555(03)00093-1","article-title":"Is bicalutamide equivalent to goserelin for prostate volume reduction before radiation therapy A prospective, observational study.","volume":"15","author":"Henderson","year":"2003","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R16-18-20210128","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.clon.2006.05.005","article-title":"Interstitial low dose rate brachytherapy for prostate cancera focus on intermediate- and high-risk disease.","volume":"18","author":"Khaksar","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R17-18-20210128","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1200\/JCO.1997.15.3.1013","article-title":"Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.","volume":"15","author":"Pilepich","year":"1997","journal-title":"J Clin Oncol"},{"key":"R18-18-20210128","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2008.17.4052","article-title":"Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.","volume":"27","author":"Souhami","year":"2009","journal-title":"J Clin Oncol"},{"key":"R19-18-20210128","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/jcem-71-4-929","article-title":"Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity.","volume":"71","author":"Zumoff","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-18-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.2005.02299.x","article-title":"Androgens, insulin resistance and vascular disease in men.","volume":"63","author":"Kapoor","year":"2005","journal-title":"Clin Endocrinol (Oxford)"},{"key":"R21-18-20210128","first-page":"3673","article-title":"Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels.","volume":"84","author":"Isidori","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-18-20210128","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","article-title":"Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.","volume":"27","author":"Laaksonen","year":"2004","journal-title":"Diabetes Care"},{"key":"R23-18-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00402551","article-title":"Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study.","volume":"35","author":"Simon","year":"1992","journal-title":"Diabetologia"},{"key":"R24-18-20210128","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00004872-199307000-00003","article-title":"Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension.","volume":"11","author":"Phillips","year":"1993","journal-title":"J Hypertension"},{"key":"R25-18-20210128","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/diacare.23.4.490","article-title":"Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study.","volume":"23","author":"Stellato","year":"2000","journal-title":"Diabetes Care"},{"key":"R26-18-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/diacare.25.1.55","article-title":"Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study.","volume":"25","author":"Oh","year":"2002","journal-title":"Diabetes Care"},{"key":"R27-18-20210128","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1210\/jc.2004-0804","article-title":"Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes.","volume":"89","author":"Dhindsa","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-18-20210128","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction.","volume":"289","author":"Bruning","year":"2000","journal-title":"Science"},{"key":"R29-18-20210128","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1210\/jc.2004-2190","article-title":"Increasing insulin resistance is associated with decrease in Leydig cell testosterone secretion in men.","volume":"90","author":"Pitteloud","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-18-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1748-1716.1992.tb09452.x","article-title":"The effects of testosterone on insulin sensitivity in male rats.","volume":"146","author":"Holmang","year":"1992","journal-title":"Acta Physiol Scand"},{"key":"R31-18-20210128","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2337\/diacare.24.12.2149","article-title":"Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial.","volume":"24","author":"Simon","year":"2001","journal-title":"Diabetes Care"},{"key":"R32-18-20210128","first-page":"329","article-title":"Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.","volume":"1","author":"Marin","year":"1992","journal-title":"European Journal of Medicine"},{"key":"R33-18-20210128","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2003-031069","article-title":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.","volume":"89","author":"Malkin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-18-20210128","first-page":"899","article-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.","volume":"154","author":"Kapoor","year":"2006","journal-title":"J Clinical Endocrinol"},{"key":"R35-18-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/tam.6.1.1.7","article-title":"Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.","volume":"6","author":"Boyanov","year":"2003","journal-title":"Aging Male"},{"key":"R36-18-20210128","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.metabol.2003.12.016","article-title":"Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control.","volume":"53","author":"Corrales","year":"2004","journal-title":"Metabolism"},{"key":"R37-18-20210128","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2337\/dc07-0359","article-title":"Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men.","volume":"30","author":"Basu","year":"2007","journal-title":"Diabetes Care"},{"key":"R38-18-20210128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2265.2008.03372.x","article-title":"Healthier lifestyle predicts higher circulating testosterone in older men.","volume":"70","author":"Yeap","year":"2009","journal-title":"Clin Endocrinol"},{"key":"R39-18-20210128","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1464-410X.2006.06416.x","article-title":"The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study.","volume":"98","author":"Barry","year":"2006","journal-title":"BJU Int"},{"key":"R40-18-20210128","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2002.01551.x","article-title":"Long-term effects of androgen deprivation therapy in prostate cancer patients.","volume":"56","author":"Basaria","year":"2002","journal-title":"Clin Endocrinol (Oxford)"},{"key":"R41-18-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3816\/CGC.2003.n.008","article-title":"Changes in body composition during combined androgen blockade for prostate cancer.","volume":"2","author":"Smith","year":"2003","journal-title":"Clin Prostate Cancer"},{"key":"R42-18-20210128","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2005-2507","article-title":"Insulin sensitivity during combined androgen blockade for prostate cancer.","volume":"91","author":"Smith","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-18-20210128","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1210\/jcem.86.9.7851","article-title":"The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer.","volume":"86","author":"Smith","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-18-20210128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/cs1040195","article-title":"Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia.","volume":"104","author":"Dockery","year":"2003","journal-title":"Clin Sci (London)"},{"key":"R45-18-20210128","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term Androgen-deprivation therapy.","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"R46-18-20210128","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"R47-18-20210128","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.urology.2007.08.012","article-title":"Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer.","volume":"70","author":"Lage","year":"2007","journal-title":"Urology"},{"key":"R48-18-20210128","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1464-410X.2007.07184.x","article-title":"Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer.","volume":"100","author":"Derweesh","year":"2007","journal-title":"BJU Int"},{"key":"R50-18-20210128","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.","volume":"99","author":"Tasi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R51-18-20210128","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"},{"key":"R52-18-20210128","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","article-title":"Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.","volume":"25","author":"DAmico","year":"2007","journal-title":"J Clin Oncol"},{"key":"R53-18-20210128","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ijrobp.2004.08.024","article-title":"Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.","volume":"61","author":"Beyer","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R54-18-20210128","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/aje\/kwh161","article-title":"Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.","volume":"159","author":"Coughlin","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R55-18-20210128","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1464-5491.2006.01838.x","article-title":"Mortality in people with type 2 diabetes in the UK.","volume":"23","author":"Mulnier","year":"2006","journal-title":"Diabet Med"},{"key":"R57-18-20210128","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","article-title":"The role of obesity and related metabolic disturbances in cancers of the colon, prostate and pancreas.","volume":"132","author":"Giovannucci","year":"2007","journal-title":"Gastroenterology"},{"key":"R58-18-20210128","doi-asserted-by":"crossref","first-page":"867S","DOI":"10.1093\/ajcn\/86.3.867S","article-title":"Metabolic syndrome, hyperinsulinaemia, and cancer.","volume":"86","author":"Hsu","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"R60-18-20210128","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","article-title":"Insulin receptor isoform A, a newly recognised, high affinity insulin-like growth factor II receptor in fetal and cancer cells.","volume":"19","author":"Frasca","year":"1999","journal-title":"Mol Cell Biol"},{"key":"R61-18-20210128","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/jnci\/djm231","article-title":"Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.","volume":"99","author":"Venkateswaran","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R62-18-20210128","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/aje\/kwj320","article-title":"The metabolic syndrome is associated with reduced risk of prostate cancer.","volume":"164","author":"Tande","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R63-18-20210128","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1158\/1055-9965.1646.13.10","article-title":"Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.","volume":"13","author":"Laukkanen","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R64-18-20210128","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(93)91943-G","article-title":"Insulin resistance in insulin-dependent diabetic patients with microalbuminuria.","volume":"342","author":"Yip","year":"1993","journal-title":"Lancet"},{"key":"R65-18-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","article-title":"Albuminuria reflects widespread vascular damage: the Steno hypothesis.","volume":"32","author":"Deckert","year":"1989","journal-title":"Diabetologia"},{"key":"R66-18-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.jhh.1001683","article-title":"Guidelines for the management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS IV.","volume":"18","author":"Williams","year":"2004","journal-title":"J Human Hypertension"},{"key":"R67-18-20210128","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of Perindopril and Indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-201210000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:57:34Z","timestamp":1786042654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201210000-00018"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e318201a406","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}